{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:56:25Z","timestamp":1790754985315,"version":"4.1.0"},"reference-count":46,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"unspecified","delay-in-days":272,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0924270826100957_as1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Electroconvulsive therapy (ECT) is an established treatment for schizophrenia. Oxidative stress has been implicated in its pathophysiology, and Thiobarbituric acid reactive substances (TBARS) are widely used markers of lipid peroxidation. However, the effect of ECT on TBARS levels remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100957_as2\">\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To compare changes in TBARS levels in schizophrenia inpatients receiving ECT plus pharmacotherapy versus pharmacotherapy alone and to examine associations between TBARS levels and clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100957_as3\">\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>\n                      Thirty-eight inpatients with schizophrenia were included (ECT + pharmacotherapy:\n                      <jats:italic>n<\/jats:italic>\n                      = 18; pharmacotherapy only:\n                      <jats:italic>n<\/jats:italic>\n                      = 20). Serum TBARS levels were measured at admission and discharge. Clinical severity was assessed using the Clinical Global Impression and Positive and Negative Syndrome Scale. Non-parametric analyses and multiple linear regression were conducted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100957_as4\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      TBARS levels did not significantly change from admission to discharge in either the ECT group (median 756.5 vs. 768.5 nmol\/L) or the pharmacotherapy group (median 644.0 vs. 693.5 nmol\/L). Percentage changes were comparable between groups (9.64% vs. 15.34%). TBARS levels were negatively correlated with age (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      = \u22120.441) and illness duration (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      = \u22120.333). Regression analysis showed that suicide history was the only significant predictor of TBARS levels (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = \u22120.402), while treatment modality was not associated with TBARS change.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100957_as5\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>ECT was not associated with statistically significant changes in TBARS levels; however, these findings should be interpreted cautiously given the exploratory nature of the study, the small sample size, and methodological limitations. The observed associations with clinical variables suggest that oxidative stress markers may have relevance in specific patient subgroups, warranting further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/neu.2026.10095","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:02:55Z","timestamp":1790751775000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Effects of electroconvulsive therapy on oxidative stress in schizophrenia"],"prefix":"10.1017","volume":"38","author":[{"given":"Ya\u011fmur","family":"Darben Azars\u0131z","sequence":"first","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi S\u0131la","family":"Ahi \u00dcst\u00fcn","sequence":"additional","affiliation":[{"name":"Ministry of Health Mamak State Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Kaya","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Dumanc\u0131","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda\u00e7","family":"Uzdo\u011fan","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"G\u00f6ka","sequence":"additional","affiliation":[{"name":"Ministry of Health Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-5207","authenticated-orcid":false,"given":"Aybeniz","family":"Civan Kahve","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/054xkpr46","id-type":"ROR","asserted-by":"publisher"}],"name":"Gazi University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"S0924270826100957_ref2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbae169"},{"key":"S0924270826100957_ref24","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2003.111"},{"key":"S0924270826100957_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa003"},{"key":"S0924270826100957_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(90)90131-2"},{"key":"S0924270826100957_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.05.007"},{"key":"S0924270826100957_ref3","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1441_20"},{"key":"S0924270826100957_ref13","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"S0924270826100957_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00111-2"},{"key":"S0924270826100957_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2003.10.001"},{"key":"S0924270826100957_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.05.007"},{"key":"S0924270826100957_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.05.016"},{"key":"S0924270826100957_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.06.018"},{"key":"S0924270826100957_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2009.01.017"},{"key":"S0924270826100957_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.11.014"},{"key":"S0924270826100957_ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100860"},{"key":"S0924270826100957_ref46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301317"},{"key":"S0924270826100957_ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001558"},{"key":"S0924270826100957_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000789"},{"key":"S0924270826100957_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.08.015"},{"key":"S0924270826100957_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.10.008"},{"key":"S0924270826100957_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.03.033"},{"key":"S0924270826100957_ref43","doi-asserted-by":"publisher","DOI":"10.1021\/pr2006796"},{"key":"S0924270826100957_ref41","first-page":"247","article-title":"Decreased superoxide dismutase activity after ECT and correlation between higher oxidant levels and poor response to ECT in depression","volume":"47","author":"V\u0131R\u0131T","year":"2010","journal-title":"Archives of Neuropsychiatry\/N\u00f6ropsikiyatri Ar\u015fivi"},{"key":"S0924270826100957_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00200-4"},{"key":"S0924270826100957_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.03.008"},{"key":"S0924270826100957_ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/745613"},{"key":"S0924270826100957_ref30","doi-asserted-by":"publisher","DOI":"10.1080\/1071576021000016391"},{"key":"S0924270826100957_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.09.032"},{"key":"S0924270826100957_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.08.024"},{"key":"S0924270826100957_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-006-9064-4"},{"key":"S0924270826100957_ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000202823"},{"key":"S0924270826100957_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.07.001"},{"key":"S0924270826100957_ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9593-0"},{"key":"S0924270826100957_ref8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0019-5545.39753","article-title":"Evaluation of antioxidant deficit in schizophrenia","volume":"50","author":"Dadheech","year":"2008","journal-title":"Indian Journal of Psychiatry"},{"key":"S0924270826100957_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"S0924270826100957_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(96)90143-X"},{"key":"S0924270826100957_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.10.011"},{"key":"S0924270826100957_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.10.061"},{"key":"S0924270826100957_ref22","first-page":"23","article-title":"Pozitif ve negatif sendrom \u00f6l\u00e7e\u011finin (PANSS) T\u00fcrk\u00e7e uyarlamas\u0131n\u0131n ge\u00e7erlilik ve g\u00fcvenilirli\u011fi","volume":"14","author":"Kostako\u011flu","year":"1999","journal-title":"T\u00fcrk psikoloji dergisi"},{"key":"S0924270826100957_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.04.026"},{"key":"S0924270826100957_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-004-0976-5"},{"key":"S0924270826100957_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-006-9214-8"},{"key":"S0924270826100957_ref4","doi-asserted-by":"publisher","DOI":"10.1023\/B:NERE.0000035811.06277.b3"},{"key":"S0924270826100957_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-010-0013-8"},{"key":"S0924270826100957_ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000077368"},{"key":"S0924270826100957_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(99)00060-X"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270826100957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:02:57Z","timestamp":1790751777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270826100957\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":46,"alternative-id":["S0924270826100957"],"URL":"https:\/\/doi.org\/10.1017\/neu.2026.10095","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"value":"0924-2708","type":"print"},{"value":"1601-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e52"}}